Navigation Links
Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,,,Transactivators

Stable reporter cell lines for signal transduction pathway readout

Lisa Hexdall Li Xu Alan Greener Mary Buchanan John Bauer Chao-Feng Zheng

Stratagene now offers the PathDetect HLR-CREB, HLR-Elk1, and HLR-cJun, cell lines F for studying signal transduction pathways that converge at the transcription factors CREB, Elk1, and c-Jun. These stable HeLa cell lines feature constitutive expression of the GAL4-CREB, GAL4-Elk1, or GAL4-cJun fusion proteins, respectively. They also contain the firefly luciferase gene, which is controlled by a promoter that responds to GAL4 fusions, as does the HLR cell line that contains only the GAL4-responsive luciferase expression plasmid. When activated by phosphorylation, these fusion proteins bind to the promoter and induce luciferase expression. Therefore, luciferase activity in stable cell lines reflects the activation status of the fusion transactivator and, hence, the activation status of corresponding signaling pathways. The effects of extracellular stimuli on signaling pathways that converge at these activators can be studied directly, without transfection. The potential applications of these cell lines include studying signal transduction and transcription mechanisms and assessing protein-protein interactions in mammalian cells. In addition, these cell lines can potentially be adapted for high-throughput drug screening.

Regulation of gene transcription by extracellular signals is pivotal for controlling growth and differentiation. Because the transcription machinery of eukaryotic cells is located inside the nucleus, signals outside the cells need to be transmitted across the cytoplasmic and nuclear membranes as well as the cytoplasm. This process of signal transmission, better known as signal transduction, involve s elaborate networks of signaling molecules (e.g., receptors, protein kinases, and phosphatases) organized in linear or parallel pathways.1,2 These signaling pathways receive diverse upstream signals that cause distinct downstream changes. Among the better-characterized signal transduction pathways are the cAMP-dependent protein kinase (PKA) pathway and the mitogen-activated protein kinase (MAPK) pathways. When activated by upstream signals, PKA or MAPK translocates into the nucleus and activates transcription factors, such as CREB and Elk1.3 Thus, the activation level of the transcription factors reflects the status of the respective kinases and upstream signaling molecules along the pathway.

To facilitate studies on the in vivo functions of gene products or extracellular stimuli, Stratagene developed the PathDetect trans-reporting systems using GAL4 fusion transactivators as pathway-specific sensors.4,5,6,7 In these systems, a fusion trans-activator plasmid that consists of the DNA binding domain of the yeast GAL4 (residues 1 to 147) protein8 and the activation domain of CREB, Elk1, or c-Jun is used to probe the activity of PKA, MAPK, and JNK, respectively.4-7,9,10 These fusion trans-activators bind to the promoter in the pFR-Luc reporter plasmid, which contains five direct repeats of the GAL4-binding element and controls luciferase expression.4 Either direct or indirect phosphorylation of the activation domain of a fusion trans-activator protein by an uncharacterized gene product activates transcription of the luciferase gene. Thus, expression levels of luciferase reflect the activation status of the respective kinases that define the signal transduction pathways.

To offer expanded capability for studying signal transduction and improved performance for adaptation to high-throughput applications, Stratagene has developed stable HeLa re porter cell lines that express the GAL4-CREB, GAL4-Elk1, or GAL4-cJun. In the HLR-CREB, HLR-Elk1, and HLR-cJun cell lines, luciferase activity reflects the activation status of the chimeric trans-activator protein and, therefore, the respective signaling pathways. By performing simple luciferase assays, researchers can directly evaluate the effects of extracellular stimuli on signaling pathways converging at CREB, Elk1, or c-Jun. Use of these cell lines eliminates transfections, thereby saving time while avoiding the variables that can be caused by fluctuations in transfection efficiencies. The HLR cell line can be used to assess protein-protein interactions in mammalian cells,11 while the HLR-CREB, HLR-Elk1, and HLR-cJun cell lines can be used to study transcription mechanisms. Another application for these cells includes adaptation for high-throughput drug screenings, since many components of signal transduction pathways are potential targets for drug development efforts.

Establishing Stable Reporter Cell Lines


To create stable reporter cell lines with the PathDetect trans-reporting systems, we tried several approaches. Figure 1 outlines our most successful protocol: We first transfected the pFR-Luc plasmid with a hygromycin expression cassette into HeLa cells. Through successive rounds of selection in antibiotic medium, hygromycin-resistant clones were isolated and tested with the PathDetect CREB, Elk1, and c-Jun trans-reporting systems. Cell lysates from these stable clones were then prepared, assayed for luciferase activity, and analyzed. One clonal line, designated as HLR for the HeLa luciferase reporter cell line, was chosen for further experimentation. It gave the highest levels of luciferase activity when tested with the trans-reporting sys tems mentioned above and had the lowest background of luciferase activity.

Next, in separate experiments, we transfected the HLR cell line with the fusion trans-activator pFA2-CREB, pFA2-Elk1, or pFA2-cJun plasmids. After performing successive rounds of selection with G418, we chose the clones that gave the best response when transfected with the positive control vectors from the PathDetect kits. These clones were then subjected to more extensive analysis.

Testing Stable Cell Lines


Genomic DNA from each stable clone was prepared and used as a template for PCR analysis to confirm that each fusion trans-activator plasmid was stably incorporated into the genomes of the selected clones. To amplify the activation domain for each reporter cell line, we used one primer specific to the GAL4 DNA-binding domain and another primer specific to each of the activation domains. Each primer set successfully amplified a product of the expected size. Analysis of HLR-CREB and HLR-Elk1 cell lines are shown in Figure 2. To further confirm the activity and specificity of these cell lines, we transfected each cell line with plasmids encoding known activators of each pathway. Upon luciferase assay of cell lysates, each cell line showed significant luciferase expression above background (Figure 3).


Additional testing included an analysis of the activation of luciferase activity in these stable cell lines by extracellular stimuli. For example, HLR-Elk1 cells were treated with known MAPK activators, including epidermal growth factor (EGF) and phorbol 12-myristate 13-acetate (PMA) (Figure 4). Luciferase expression in the HLR-Elk1 cells wa s five times higher than the control, when cells were treated with 100 ng/ml of EGF, and almost 50-fold higher when cells were challenged with PMA (60 ng/ml). Dulbeccos modified Eagles medium (DMEM) and dimethylsulfoxide (DMSO) were used as negative controls.


For the final testing, we confirmed purity by screening for mycoplasma and established viability after freezing in liquid nitrogen. The HLR, HLR-CREB, HLR-Elk1, and HLR-cJun cell lines are available as frozen stocks containing 5 x 105 cells; each cell line includes the corresponding positive and negative control plasmids.


The HLR-CREB, HLR-Elk1, and HLR-cJun stable cell lines offer a new approach and added convenience for studying the intricate interactions of signal transduction pathways. These cell lines can be used to evaluate whether a new gene product or extracellular stimulus is involved in signaling pathways that converge at CREB, Elk1, and c-Jun transcription factors; furthermore, the cell lines can be used to identify which step along the pathway is targeted. The HLR-CREB, HLR-Elk1, and HLR-cJun cell lines can be adapted for high-throughput screening of inhibitors or activators of these signaling pathways. In addition, the HLR cell line can be used in a variety of other applications, such as assessing protein-protein interactions in GAL4-derived mammalian two-hybrid systems.

  1. Boulikas, T. (1995) Critical Rev. Eukaryotic Gene Exp. 5: 1-77.

  2. Karin, M. and Hunter, T. (1995) Curr. Biol. 5: 747-757.

  3. Treisman, R. (1996) Curr. Opin. Cell Biol. 8: 205-215.

  4. Xu, L., et al. (1997) Strategies 10: 1-3.

  5. Xu, L., et al. (1997) Strategies 10: 79-80.

  6. Xu, L. and Zheng, C.-F. (1997) Strategies 10: 81-83.

  7. Sanchez, T., et al. (1998) Strategies 11: 52-53.

  8. Sadowski, I. and Ptashne, M. (1989) Nucl. Acid Res. 17: 7539.

  9. Marais R., et al. (1993) Cell 73: 381-393.

  10. Smeal, T., et al. (1994) EMBO J. 13: 6006-6010.

  11. Dang, C.V., et al. (1991) Mol. Cell. Biol. 11: 945-962.



Page: All 1 2 3 4 5 6

Related biology technology :

1. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
2. Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39)
3. Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
4. Promegas Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar
5. Versatile Reporter Vectors for Monitoring Viral Transduction
6. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
7. Genetic Reporter Systems
8. Genetic Reporter Systems
9. Detection of Reporter Gene Activity in Cell Cultures and Murine Epidermis After Helios Gene Gun-Mediated Particle Bombardment
10. A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20)
11. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
Post Your Comments:

(Date:10/8/2015)...  The ALS Association, in partnership with Prize4Life, is ... revolutionize communication technology solutions for people living with ALS. ... (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that ... spinal cord. Eventually, people with ALS lose the ability ... to total paralysis and death within two to five ...
(Date:10/8/2015)... ... ... Talon Innovations, a provider of Precision Machined Products and Assemblies ... one of three finalists for the Minnesota Business magazine’s Manufacturing Award in the category ... was recognized as a nominee for this competitive award. , The “Best in ...
(Date:10/7/2015)... , Oct. 7, 2015 Boston ... the start of the Boston Scientific Connected Patient ... advancements in the use of remote patient monitoring to ... designers and entrepreneurs can submit their ideas and collaborate ... ( ). Cambridge, MA ...
(Date:10/7/2015)... -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV ) ("ContraVir" or ... and commercialization of targeted antiviral therapies, today announced the ... of its common stock and warrants to purchase up ... a fixed combined price to the public of $3.00. ... issued separately.  The warrants will be exercisable for a ...
Breaking Biology Technology:
... Turku, Finland, show that the GSM mobile phone electromagnetic ... temporal areas of the hemisphere next to the antenna. ... the GSM signal for 33 minutes. The study, initiated ... Turku, was methodologically unique combining the expertice in brain ...
... Generex Biotechnology Corporation ( ) (OTCBB: ... University Campus Bio-Medico in Rome, Italy, made a ... Oral-lyn™ buccal insulin spray on September 14, 2011 ... Diabetes (EASD) annual meeting in Lisbon, Portugal. ...
... This evening, Novo Nordisk awarded sponsorships totaling $80,000 to ... educate people living with type 2 diabetes on how ... of long-term diabetes related complications. The sponsorships are part ... new initiative that aims to promote enduring, sustainable change ...
Cached Biology Technology:
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
(Date:9/10/2015)... Report Details Emerging Biological ... and Revenue Prospects to Help You Stay Ahead ... new drug classes? Get the latest technological and ... market data and industry knowledge, benefitting your influence. ... and sales predictions. Visiongain,s new study reveals ...
Breaking Biology News(10 mins):
... Warwick have discovered how a protein from a bacterium acts ... as a basis of a new range of natural insecticides. It had ... with the help of a bacterium which they harbour inside their intestine. ... which helps the nematode to kill and feed on the dead ...
... a study that could help reveal how illusions are produced ... of Medicine have found new evidence of rapid integration of ... which provide new insight into neural mechanisms by which visual ... published online in the April 12 edition of the Journal ...
... University of Toronto is revealing biochemical processes responsible for ... pave the way for pharmaceutical applications. , A ... Cell describes how U of T and Johns Hopkins ... that play an important role in human health and ...
Cached Biology News:
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
Reacts with methylated DNA from plants and vertebrates...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
Biology Products: